Page 4,730«..1020..4,7294,7304,7314,732..4,7404,750..»

Stem Cell Injections Medical Course – Video

Posted: Published on December 25th, 2013

Stem Cell Injections Medical Course For Educational Use Only - Fair Use - During a surgery for a meniscus tear Barbee 54 discovered that she had an appreciable loss of cartilage and her knee ne... By: Abiezer Abigail … Continue reading

Posted in Stem Cell Injections | Comments Off on Stem Cell Injections Medical Course – Video

Stem Cell Blog – Cell therapy clinical trials – 2012 report …

Posted: Published on December 25th, 2013

This is an annual report of registered clinical trials in cell therapy. Every year I overview some tracked data from international clinical trials databases. You can see 2011 report here. Definitions I tracked clinical trials which fall in definition of cell therapy: administration of living cells in human with therapeutic purpose. I included tissue engineering, cellular gene therapy and devices for cell processing. I tracked all clinical trials which were registered from Jan.1, 2012 to Dec. 31, 2012 in international databases. Exclusion criteria: Trials, assessing cell therapy for homologous use were excluded from analysis. Examples: (1) hematopoietic cells for recovery of blood formation (in hematological malignancies) or (2) ex vivo expansion of hematopoietic cells for enhancement of engraftment in hematological malignancies. Hand coding and data collection Hand coding included: Search key words: cell therapy stem cell cord blood umbilical cord bone marrow cancer vaccine tissue engineering Total number of trials tracked: 226 Number of duplications between databases: 6 Databases The following databases were scanned: US NCT (NIH-FDA) European EUCTR Japanese JPRN Indian CTRI Chinese ChiTCR Iranian IRCT Australian/NZ ANZCTR UK ISRCTN Dutch NTR South Korean CRIS All international databases, except NCT, were scanned via WHO Search Portal. Databases representation: Demographics: … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Stem Cell Blog – Cell therapy clinical trials – 2012 report …

FRONTLINE CANCER: Working to eliminate the cancer stem cells that sustain disease

Posted: Published on December 25th, 2013

By Scott M. Lippman Chemotherapies seek out cancer cells by targeting a fundamental characteristic of cancer cells: their rapid and frequent replication. But in doing so, these drugs can destroy healthy cells that also grow quickly. The result: adverse effects like hair loss and nausea.Worse, the benefits of chemotherapy are frequently short-lived. Seemingly beaten by chemotherapy, a cancer can suddenly return, spreading from its original site to other parts of the body with often catastrophic consequences. Ninety percent of cancer-related deaths are due to metastasis, and almost every cancer can be metastatic. Why do cancers recur when therapeutic evidence suggests theyve been wiped out? The answer lies in a type of cancer cell with the powerful characteristic of normal stem cells the ability to self-renew or regenerate. Sott M. Lippman, M.D. Unlike normal stem cells, however, this ability in cancer stem cells does not turn off. Cancer stem cells are a relatively new phenomenon to cancer science. Conclusive evidence of their existence was found only in 1994, though in the years since, extraordinary efforts have been made to better understand them in order to destroy them. Its a daunting task. Cancer stem cells persist in small communities, often tucked away … Continue reading

Posted in Stem Cell Human Trials | Comments Off on FRONTLINE CANCER: Working to eliminate the cancer stem cells that sustain disease

'I will walk.' Kim Dennie's journey of hope brings her closer to goal

Posted: Published on December 25th, 2013

Niagara This Week - St. Catharines THOROLD -- Following a month-long stay in China, Kim Dennie has more faith now than she ever did that her wheelchair will be a part of her past. On Jan. 13, Dennie left her home in Allanburg on a journey to China for stem cell therapy treatments not available in Canada. After an assessment, Dennie was told the words she has so longed to hear since her life was changed nearly four years ago. "They told me that my condition is not that bad and I should be able to walk again," Dennie told This Week. "With the right mindset and persistence and continued therapy, I will walk." In July 2003 Dennie, and her two children, 13-year-old Brittany and 12-year-old Jamie, were returning from a trip to Sudbury. The car she was riding in was broadsided by an oncoming vehicle. The car slammed into the passenger side door where she was sitting. Dennie broke her back, neck, shoulder and pelvis and hasn't been able to walk since. The initial diagnosis was complete spinal chord injury, leaving her paralyzed from the waist down. Three months later she was wiggling the toes on her left foot … Continue reading

Comments Off on 'I will walk.' Kim Dennie's journey of hope brings her closer to goal

Cyberonics, Inc. (CYBX): New Analyst Report from Zacks Equity Research – Zacks Equity Research Report

Posted: Published on December 25th, 2013

Summary: Cyberonics posted a meaningful 13.6% rise in its second-quarter fiscal 2014 EPS to $0.50, and a healthy 12% increase in revenues to $70.1 million. The numbers also surpassed the Zacks Consensus Estimates of $0.49 and $69 million, respectively. Cyberonics continued to gain from a solid foothold in the epilepsy market and strong overseas business. Further penetration in the still untapped epilepsy market should catalyze growth. The company's lucrative pipeline is another upside. Attractive share buyback continues to boost investors' return. However, the setback on TRD indication and lower contributions from Japan remain major downsides. The situation in Japan is not likely to improve in this fiscal year, and margin pressure represents another area of concern. The company also faces a tough competitive landscape and a challenging macroeconomic scenario. Thus, we remain Neutral. Overview: Cyberonics Inc. (CYBX) is a medical technology company with core expertise in neuromodulation. The company provides Vagus Nerve Stimulation (VNS) therapy for the treatment of refractory epilepsy and treatment-resistant depression (TRD). The VNS Therapy System is delivered from a small pacemaker-like generator implanted in the chest that sends preprogrammed, intermittent, mild electrical pulses through the vagus nerve in the neck to the brain. VNS Therapy for … Continue reading

Comments Off on Cyberonics, Inc. (CYBX): New Analyst Report from Zacks Equity Research – Zacks Equity Research Report

Autism center names new clinical director

Posted: Published on December 25th, 2013

POSTED ON BEHALF OF FREEMAN HEALTH SYSTEM Autism center names new clinical director JOPLIN, Mo.Bill & Virginia Leffen Center for Autism proudly announces its new clinical director, Kristy Parker. A board-certified behavior analyst, Parker joined Freeman in 2011. As clinical director, she serves on the Autism Diagnostic Team and oversees all clinical programming, including day treatment, the Special Education Center, teen and adult classes, outpatient services, Missouri Department of Mental Health services, and First Steps services. Additionally, she oversees parent training and staff training and development. Parker earned a masters degree in education/special education with an emphasis in autism from the University of Missouri in Columbia. She also holds a masters degree in psychology/applied behavior analysis from the University of Nevada in Reno, Nev. Kristy brings a wealth of experience to the role of clinical director, said Vicky Mieseler, Ozark Center Vice President of Clinical Services. Her compassion, knowledge, and expertise will serve to strengthen the services we offer to children and families dealing with autism spectrum disorders. ### Excerpt from: Autism center names new clinical director … Continue reading

Comments Off on Autism center names new clinical director

Health Beat: Bursting blood clots: Medicine’s next big thing?

Posted: Published on December 25th, 2013

CINCINNATI - If you're having a stroke, it's crucial that you get medical help as quickly as possible. The right treatment can mean the difference between life and death and reduce future impairment. Now, doctors are testing a possible new, medical breakthrough for stroke victims. "One side of the body doesn't work. They can't speak. They can't see," said Dr. Arthur M. Pancioli, professor and chairman in the department of emergency medicine, University of Cincinnati College of Medicine. Most strokes are caused by a blood clot that blocks the flow of blood to the brain. If you get help within three hours, you can get a drug called TPA, but Pancioli, an expert in emergency medicine, warned of the risks. "With that drug, one in about 16 patients that you treat will have bleeding into the brain," Pancioli said. Dr. George Shaw and researchers at the University of Cincinnati College of Medicine are testing a breakthrough technique to dissolve human blood clots more quickly, without the risk of bleeding. Theyre using a natural enzyme called plasmin. "It's the most effective therapy we've ever looked at," said Shaw, emergency medicine associate professor, University of Cincinnati College of Medicine. The plasmin is … Continue reading

Comments Off on Health Beat: Bursting blood clots: Medicine’s next big thing?

St. Luke’s recognized for care of stroke patients

Posted: Published on December 25th, 2013

St. Lukes The Woodlands Hospital received the American Heart Association/American Stroke Associations Get With The Guidelines Stroke Silver Plus Quality Achievement Award. The award recognizes the hospitals commitment and success in implementing excellent care for stroke patients. SLWH also was recognized in 2012 by the American Stroke Association with the Get With The Guidelines Stroke Bronze Quality Achievement Award. These prestigious awards are truly the result of the outstanding vision and leadership of our medical staff. Over the last 18 months, we have made a concentrated effort to not just meet, but to exceed the measures set forth by the American Stroke Association, said Debra Sukin, CEO of St. Lukes The Woodlands Hospital. Our stroke program as an essential component of our neuroscience program, which also encompasses clinical, intervention, surgical core and gamma knife treatment. We are proud to be recognized. The hospital achieved an 85 percent or higher adherence to all Get With The Guidelines-Stroke Quality Achievement indicators for 12 consecutive months and also achieved 75 percent or higher compliance with six of 10 Get With The Guidelines-Stroke Quality Measures the reporting initiatives that measure quality of care. These measures include aggressive use of medications, such as antithrombiotics, anticoagulation … Continue reading

Comments Off on St. Luke’s recognized for care of stroke patients

Breaking Down Tony Romo’s Back Injury, Recovery Timeline from a Herniated Disc

Posted: Published on December 25th, 2013

Seemingly out of nowhere, Dallas Cowboys quarterback Tony Romo may miss the rest of the 2013 season due to a back injury known as a herniated intervertebral disc. ESPN's Adam Schefter broke the news first. His colleague Chris Mortensen soon provided more details: Herniated lumbar discs are a relatively common injury throughout the NFLand life in general.In fact, low back painwith or without herniationrepresents one of the most frequent of all chief complaints at doctors' offices. Unfortunately, Romo's came at one of the most inopportune times imaginable. Furthermore, the entire story still remains unclearat least partially. According to Pro Football Talk's Curtis Crabtree, neither owner Jerry Jones nor head coach Jason Garrett are throwing in the towel: Perhaps the injury is not as severe, after all. Or perhaps Jones and Garrett are merely posturing leading up to the Week 17 matchup with the PhiladelphiaEaglesa game that will decide the NFC East champion. To attempt to make sense of what's going onand what's notit helps to take a look at the injury itself. What Are Intervertebral Discs? See original here: Breaking Down Tony Romo's Back Injury, Recovery Timeline from a Herniated Disc … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Breaking Down Tony Romo’s Back Injury, Recovery Timeline from a Herniated Disc

Cerebral palsy – MayoClinic.com – Mayo Clinic

Posted: Published on December 25th, 2013

Our weekly general interest e-newsletter keeps you up to date on a wide variety of health topics. Cerebral palsy is a disorder of movement, muscle tone or posture that is caused by an insult to the immature, developing brain, most often before birth. Signs and symptoms appear during infancy or preschool years. In general, cerebral palsy causes impaired movement associated with exaggerated reflexes, floppiness or rigidity of the limbs and trunk, abnormal posture, involuntary movements, unsteadiness of walking, or some combination of these. People with cerebral palsy may have difficulty with swallowing and commonly have eye muscle imbalance. People with cerebral palsy may have reduced range of motion at various joints of their bodies due to muscle stiffness. The effect of cerebral palsy on functional abilities varies greatly. Some people are able to walk while others aren't able to walk. Some people show normal to near normal intellectual function, but others may have intellectual disabilities. Epilepsy, blindness or deafness also may be present. People with cerebral palsy often have underlying developmental brain abnormalities. Go here to see the original: Cerebral palsy - MayoClinic.com - Mayo Clinic … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Cerebral palsy – MayoClinic.com – Mayo Clinic

Page 4,730«..1020..4,7294,7304,7314,732..4,7404,750..»